PM Modi presence to motivate company in quest to bridge unmet healthcare needs: Zydus Cadila

The Zydus family comprising 25,000 Zydans stands committed to the ''Aatmanirbhar Bharat'' mission and offering the nation safe and efficacious vaccines, therapeutics and diagnostics to fight COVID 19,Zydus Cadila said.

Published On 2020-11-28 13:31 GMT   |   Update On 2020-11-28 13:32 GMT

New Delhi: Drug firm Zydus Cadila on Saturday said the presence of Prime Minister Narendra Modi at its Zydus Biotech Park will motivate the company to scale greater heights in its pursuit to bridge unmet healthcare needs.Modi visited Zydus Cadila's manufacturing facility near Ahmedabad, as he began his three-city visit to review ongoing coronavirus vaccine development work."His inspiring...

Login or Register to read the full article

New Delhi: Drug firm Zydus Cadila on Saturday said the presence of Prime Minister Narendra Modi at its Zydus Biotech Park will motivate the company to scale greater heights in its pursuit to bridge unmet healthcare needs.

Modi visited Zydus Cadila's manufacturing facility near Ahmedabad, as he began his three-city visit to review ongoing coronavirus vaccine development work.

"His inspiring presence will motivate us to scale greater heights in our quest to bridge unmet healthcare needs," Zydus Cadila said in a regulatory filing.

The Zydus family comprising 25,000 Zydans stands committed to the ''Aatmanirbhar Bharat'' mission and offering the nation safe and efficacious vaccines, therapeutics and diagnostics to fight COVID-19, it added.

Zydus Cadila had earlier announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it commenced phase-II clinical trials from August.

Also Read: PM Modi Reviews Vaccine Development At Zydus Cadila Facility


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News